NCT03982355View on ClinicalTrials.gov

Development and Validation of a Tumour Oxygenation Monitoring Probe

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

August 9, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Cancer
Interventions
DEVICE

DRS probe

The Oxygenation measurements of the novel diffuse reflectance spectroscopy probe

Trial Locations (1)

W21NY

Imperial College London, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT03982355 - Development and Validation of a Tumour Oxygenation Monitoring Probe | Biotech Hunter | Biotech Hunter